UV5000W Handle

K253226 · Uroviu Corporation · FAJ · Oct 23, 2025 · Gastroenterology, Urology

Device Facts

• Record ID: K253226
• Device Name: UV5000W Handle
• Applicant: Uroviu Corporation
• Product Code: FAJ · Gastroenterology, Urology
• Decision Date: Oct 23, 2025
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 876.1500
• Device Class: Class 2

Intended Use

The UV5000W Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics.

Device Story

The UV5000W Handle is a reusable, handheld component of an endoscopic system used in hospitals and physician offices. It connects to various UroViu cannulas to capture real-time video of the urethra, bladder, cervical canal, or uterine cavity. The device features an integrated 5-inch LCD monitor for direct visualization by the physician during procedures. It also includes a wireless relay to transmit images to an external monitor. Users control illumination brightness and capture still images or video via buttons on the handle. The device is powered by a rechargeable 21700 Lithium-Ion battery. By eliminating the need for a physical cable connection to a separate video tower, the device improves maneuverability and provides immediate visual feedback, aiding in diagnostic accuracy and clinical decision-making.

Clinical Evidence

Bench testing only. No clinical or animal studies were conducted. Performance was verified through bench testing of image quality, battery discharge, service life, electrical safety (IEC 60601-1), EMC (IEC 60601-1-2), and thermal safety (IEC 60601-2-18).

Technological Characteristics

Reusable handle, 178mm length, 38mm diameter, 345g weight. Integrated 5-inch LCD (1024x768 resolution). Powered by 21700 Lithium-Ion rechargeable battery (3.63V, 4900mA). Connectivity includes wireless relay for external transmission. Compliant with IEC 60601-1, IEC 60601-1-2, and IEC 60601-2-18. Cleaning/disinfection via chemical towelettes (Super Sani-Cloth/CaviWipe). Software version 1.0.100.

Indications for Use

Indicated for use with UroViu Cannula systems to permit visualization of the urethra, bladder, cervical canal, and uterine cavity for diagnostic purposes. Contraindications are as described in each specific UroViu cannula's instructions for use.

Regulatory Classification

Identification

An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Special Controls

*Classification* —(1)*Class II (special controls).* The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

Predicate Devices

• UV5000 Handle (K250797)

Submission Summary (Full Text)

{0}

FDA U.S. FOOD & DRUG ADMINISTRATION

October 16, 2025

UroViu Corporation
Thomas Lawson
Director, Regulatory Affairs
4546 El Camino Real
Suite 214
Los Altos, California 94022

Re: K253226
Trade/Device Name: UV5000W Handle
Regulation Number: 21 CFR 876.1500
Regulation Name: Endoscope and accessories
Regulatory Class: II
Product Code: FAJ
Dated: September 29, 2025
Received: September 29, 2025

Dear Thomas Lawson:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: The Center for Devices and Radiological Health (CDRH) does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register.

U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

{1}

K253226 - Thomas Lawson
Page 2

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-

{2}

K253226 - Thomas Lawson
Page 3

assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

MARK J. ANTONINO -S

Mark J. Antonino, M.S.
Assistant Director
DHT3B: Division of Reproductive, Gynecology, and Urology Devices
OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

{3}

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.

Submission Number (if known)
K253226

Device Name
UV5000W Handle

Indications for Use (Describe)
The UV5000W Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics.

Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)

## CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
[e-mail]

> "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}

UroViu Corporation
K253226
Page 1 of 9

# 510(k) SUMMARY

## General Information

| Submitter | UroViu Corporation |
| --- | --- |
| Address | 4546 El Camino Real
Suite 214
Los Altos, CA 94022 |
| Correspondence Person | Thomas Lawson, PhD
Director, Regulatory Affairs |
| Contact Information | Email: [e-mail]
Phone: [phone] |
| Date Prepared | October 15, 2025 |

## Proposed Device

| Trade Name | UV5000W Handle |
| --- | --- |
| Common Name | Endoscope and accessories |
| Regulation Number and Classification Name | 21 CFR§876.1500
Cystoscope and Accessories, Flexible/Rigid |
| Product Code | FAJ |
| Regulatory Class | II |
| Note: This is the first 510(k) submission for this device. | |

## Predicate Device

| Trade Name | UV5000 Handle |
| --- | --- |
| Common Name | Endoscope and accessories |
| Premarket Notification | K250797 |
| Regulation Number and Classification Name | 21 CFR§876.1500
Cystoscope and Accessories, Flexible/Rigid |
| Product Code | FAJ |
| Regulatory Class | II |
| Note: This predicate device has not been subject to a design-related recall. | |

## Device Description

The UV5000W Handle is a component of UroViu cystoscope and hysteroscope systems. The UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V connect to the UV5000W Handle to become an endoscopic system that is intended to allow visualization of the urethra, bladder, cervical canal, and uterine cavity for the purpose of performing diagnostics. This 510(k) discloses the modifications

{5}

UroViu Corporation
K253226
Page 2 of 9

made to the UV5000 Handle (K250797) with the capability of transmitting the images captured wirelessly to an external monitor.

## Indications for Use

The indication for use for the UV5000W Handle is:

The UV5000W Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics.

## Comparison to the Predicate Device

The focus of this Traditional 510(k) is the Handle component of the UroViu cystoscope and hysteroscope systems that were reviewed in previous 510(k) submissions. The UV5000W Handle is substantially equivalent to the UV5000 Handle based upon the following equivalences:

1. The intended use of both devices is the same.
2. Both devices provide the means for the physician to view the urethra and bladder or cervical canal and uterine cavity via the video monitor that is integrated into the body of the handle.

Table 1 shows the comparison of the UV5000W Handle (the subject of this submission) to the predicate device, the UV5000 Handle. The similarities between the two devices satisfy the criteria for a 510(k) notice.

{6}

UroViu Corporation

K253226

Table 1. Comparison of the UV5000W Handle to the predicate device, the UV5000 Handle.

| | Subject Device UV5000W Handle UroViu Corp. (This submission) | Predicate Device UV5000 Handle UroViu Corp. K250797 | Equivalence |
| --- | --- | --- | --- |
| Device Overview | | | |
| Device Class | II | II | Same |
| FDA Product Code | FAJ | FAJ | Same |
| Product Classification | 21 CFR 876.1500 | 21 CFR 876.1500 | Same |
| Intended Use | Used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics | Used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics | Same |
| Indication for Use | The UV5000W Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics. | The UV5000 Handle is to be used with UroViu Cannula Uro-G HD, Uro-G, Uro-V, Uro-N, and Hystero-V and is intended to be used to permit viewing of the urethra and bladder or cervical canal and uterine cavity for the purpose of performing diagnostics. | Same |
| Contraindications | As described in each UroViu cannula's instructions for use | As described in each UroViu cannula's instructions for use | Same |
| --- | --- | --- | --- |

{7}

UroViu Corporation
K253226
Page 4 of 9

| Technical Characteristics | | | |
| --- | --- | --- | --- |
| Device Identity | UV5000W | UV5000 | N/A |
| Components | • 1 piece handle
• 1 piece charging cradle
• 1 piece USB cable
• 1 Wireless Relay | • 1 piece handle
• 1 piece charging cradle
• 1 piece USB cable | Equivalent
The wireless relay does not affect the intended use of the UV5000W Handle |
| Length | 178 mm | 178 mm | Same |
| Diameter | 38 mm | 38 mm | Same |
| Weight | 345 g | 345 g | Same |
| Monitor | 5 inches diagonal
125.4 mm
horizontal
91.4 mm vertical | 5 inches diagonal
125.4 mm
horizontal
91.4 mm vertical | Same |
| Input format | RGB | RGB | Same |
| Effective pixels | 1280 x 720 | 1280 x 720 | Same |
| LCD resolution | 1024 x 768 | 1024 x 768 | Same |
| LCD display resolution | 0.8 million pixels | 0.8 million pixels | Same |
| Power supply | 21700 Lithium Ion rechargeable battery | 21700 Lithium Ion rechargeable battery | Same |
| Voltage of fully charged battery | 3.63 V | 3.63 V | Same |
| Time to obtain full charge | 4 hours | 4 hours | Same |
| Operating time after fully charged | 2 hours | 2 hours | Same |
| Battery capacity | 4900 mA | 4900 mA | Same |

{8}

UroViu Corporation
K253226
Page 5 of 9

| Biocompatibility | N/A
Does not contact the patient & the user wears gloves while using the device | N/A
Does not contact the patient & the user wears gloves while using the device | Same |
| --- | --- | --- | --- |
| Operational Characteristics | | | |
| Electrical Safety | IEC 60601-1 & IEC 60601-2-18 compliant | IEC 60601-1 & IEC 60601-2-18 compliant | Same |
| EMC | IEC 60601-2 compliant | IEC 60601-2 compliant | Same |
| Adjust brightness of illumination of the LEDs | Adjust by depressing a button on the handle to change settings | Adjust by depressing a button on the handle to change settings | Same |
| Images or video capture | Capture still images (photo) or video during a procedure by depressing the camera button on the handle | Capture still images (photo) or video during a procedure by depressing the camera button on the handle | Same |

{9}

UroViu Corporation
K253226
Page 6 of 9

| Cleaning, disinfecting, and sterilizing | The handle is not sterile.
The handle is cleaned and disinfected following directions in the instructions for use (IFU):
• Wipe the surface with a Super Sani-Cloth or CaviWipe towelette
• Surface to remain visibly wet for 3 minutes
• After 3 minutes, allow the handle to air dry for 5 minutes

Wet a sterile pad with sterile water and wipe all exposed surfaces of the handle. | The handle is not sterile.
The handle is cleaned and disinfected following directions in the instructions for use (IFU):
• Wipe the surface with a Super Sani-Cloth or CaviWipe towelette
• Surface to remain visibly wet for 3 minutes
• After 3 minutes, allow the handle to air dry for 5 minutes

Wet a sterile pad with sterile water and wipe all exposed surfaces of the handle | Same
Same |
| --- | --- | --- | --- |
| Frequency of use | Reusable | Reusable | Same |
| --- | --- | --- | --- |
| Duration of use | < 24 hours | < 24 hours | Same |
| Location of use | Hospitals and physician offices | Hospitals and physician offices | Same |

{10}

UroViu Corporation
K253226
Page 7 of 9

| Mechanism of Action | | | |
| --- | --- | --- | --- |
| Operating Principles | Rather than run a cable from the cystoscope to a separate video monitor as is required for all other cystoscopes, the LCD monitor is integrated into the body of the handle of the UroViu cystoscope & hysteroscope system so that the user can see images of the tissue and anatomical structures directly and in real time as the cannula is being advanced to and within the bladder or the cervical canal and uterine cavity.

In addition, the image can be transmitted to an external monitor via WIFI with the use of a separate wireless relay device. | Rather than run a cable from the cystoscope to a separate video monitor as is required for all other cystoscopes, the LCD monitor is integrated into the body of the handle of the so that the user can see images of the tissue and anatomical structures directly and in real time as the cystoscope or hysteroscope is being advanced to and within the bladder or the cervical canal and uterine cavity . | Equivalent
WIFI transmission of the images to an external monitor does not alter the intended use of the Handle |
| Performance Testing | | | |
| Bench testing for Image Quality | Pass | Pass | Same |
| Battery change and discharge test | Pass | Pass | Same |
| 15-month service life | Pass | Pass | Same |
| Software (SW) | | | |
| SW version | 1.0.100 | 1.0 | Equivalent
The UV5000W SW version was developed separately to permit wireless transmission but it used version 1.0 |

{11}

UroViu Corporation
K253226
Page 8 of 9

| Level of Concern | Moderate | Moderate | Same |
| --- | --- | --- | --- |
| General functions of the software | • Initialize and setup video processing software
• Initialize LCD display control
• Initialize user interface (menus, touch screen)
• Initialize recording, storage, and playback of video and still images
• Facilitate wireless transmission of images to an external monitor | • Initialize and setup video processing software
• Initialize LCD display control
• Initialize user interface (menus, touch screen)
• Initialize recording, storage, and playback of video and still images | Equivalent |

## Performance Data

All necessary performance testing were conducted:

- Tip temperature during use
- Cybersecurity
- Electrical safety and electromagnetic compatibility testing

The device was found to meet the compliance requirements for electrical safety as specified in ISO 60601-1 including provisions for EMC safety in ISO 60601-1-2 and IEC 60601-2-18 Medical electrical equipment - Part 2-18: Particular requirements for the basic safety and essential performance of endoscopic equipment, including thermal safety.

{12}

UroViu Corporation
K253226
Page 9 of 9

## Preclinical (Animal) Studies

Bench testing was sufficient to demonstrate performance of the device. No preclinical testing of the subject device was necessary.

## Clinical Studies

Bench testing was sufficient to demonstrate performance of the device. No clinical testing of the subject device was necessary.

## Conclusion

The information submitted in this premarket notification confirms that the minor differences between the UV5000W Handle and the predicate raise no new questions of safety and effectiveness. Therefore, the UV5000W Handle is substantially equivalent to the identified predicate device.